Cognitively Normal (CN) Subjects: based on MMSE scores, CDR, and GDS.The first session will involve screening to confirm eligibility and administration of the cognitive testing procedures, while the second session will involve the MRI protocol.Ĭlinical diagnosis based on recent (within 1 year) consensus meeting, cross-referenced with standard neuropsychological scores:
Participants will be asked to come in for two separate sessions. The current protocol strictly for a research study and there will be no "standard care" provided. As part of the current study, all subjects will receive both the Neurotrack Visual Paired-Comparison (VPC) Task and MRI scans. Subjects will be elderly individuals who are participating in ongoing research at the NYU Alzheimer's Disease Center (ADC) and who have received the standard ADC clinical evaluation within the past year, including a medical-neurological evaluation, neuro-psychological assessment and structural neuroimaging (MRI). Patients and research subjects could be screened for medial temporal lobe (MTL) impairment using inexpensive, widely available, safe, and non-invasive technology. The Neurotrack test has the potential to dramatically alter the current methods used for detecting cognitive deficits. Why Should I Register and Submit Results?.